Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario's life sciences sector - "Diversity of Members, Unity of Voice".
AvidBiologics Closes New Financing Round
Wednesday, October 1, 2014
AvidBiologics Inc., an oncology drug development company, today announced the closing of a financing round. The company is founded on antibody-drug conjugate (ADC) technologies co-developed with the National Research Council of Canada (NRC).
Celebrate National Biotech Week
Friday, September 26, 2014
I am writing to you as a member of Canada's biotech community to invite you to celebrate National Biotech Week September 26 - October 3, 2014. Joined together by the National Biotech Accord members from coast to coast we celebrate the incredible innovations occurring throughout the variety of health, agriculture, and industrial facets of the industry with applications to re-engineer traditional Canadian industries such as energy, aerospace, mining, and forestry. With thousands of participants each year National Biotech Week provides a forum to collaborate and showcase the impact the biotechnology industry is having on the countrys economy and the daily lives of Canadians.
Partnership Helps Drive Innovation at iHub
Friday, September 12, 2014
A collaboration between the District School Board of Niagara and Innovate Niagara will provide start-up companies working out of the newly minted iHub in St. Catharines with more support in bringing their products to market.
CloudDX makes final cut in $10M Tricoder XPrize contest
Tuesday, September 2, 2014
A tiny company from Mississauga, Ont., has made the final cut of companies competing to make a science fiction dream a reality and win the $10-million Qualcomm Tricorder XPrize. CloudDX is among 10 finalists for the 3-1/2-year-old prize, which aims to develop a consumer-focused, mobile device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics.
Proteocyte Diagnostics initiates a Cost-Effectiveness Analysis with support from Mitacs
Tuesday, September 2, 2014
Proteocyte Diagnostics Inc. of Toronto announced their collaboration with Mitacs Accelerate to conduct an economic evaluation of its predictive technology for the early detection of oral cancer. Weve partnered with Mitacs before with great success, said Dr. Mario Thomas, Chief Commercialization Officer of Proteocyte Diagnostics. The intent of this study is to show the value for money of identifying oral cancer before it happens. We know that private payers and governments will want solid data supporting the value of Straticyte. This is a groundbreaking diagnostic test for early identification of oral cancers that has the potential to save lives, improve quality of life and reduce healthcare costs.